TGFB1 and pulmonary arterial hypertension: Disruption of TGF-β signaling and increased TGF-β have been implicated in PAH-associated cardiac and respiratory toxicity (Curfs et al., 2005; Qin et al., 2018; Wang et al., 2021; Ma et al., 2022).